Hematology and Oncology

Parent: Medical Student Research Forum Posters

eScholarship stats: Breakdown by Item for July through October, 2026

ItemTitleTotal requestsDownloadView-only%Dnld
83v9859dPathogenesis of Endometriosis in Non-Human Primates: A Critical Literature Review111476442.3%
3990f2bjWhich non-phamacologic interventions are most effective at addressing chemotherapy related cognitive impairment (CRCI) in adolescent and young adult cancer survivors?97455246.4%
54q9h3d9Low Income Areas Predict T Stage in Patients with Head and Neck Cancer94187619.1%
65p3521qSarcopenia and Frailty as Predictors of Surgical Morbidity and Oncologic Outcomes in Retroperitoneal Sarcoma94336135.1%
0fr155c7MEK Inhibitor-Based Combination Strategies in Selected Molecular Subsets of Non-Small Cell Lung Cancer (NSCLC): rationale for the Design of Phase I Clinical Trials93227123.7%
1kh858pmFragmentation of Care for Young Adults with Sickle Cell Disease in California91266528.6%
0009k5hnDeveloping PRISM-Spanish: A psychosocial skills-based intervention for Spanish-speaking adolescents and young adults with cancer84265831.0%
6kw1t6b1An Integrated Multidisciplinary Evaulation Platform and Early Experience for Precision Therapy in Resectable NSCLC84354941.7%
2w0363m2Views of Non-Physician Stakeholders on Barriers & Facilitators to AYA Cancer Care in Latin America71224931.0%
52n3v75rFeasibility of a Symptomatic Screening Program for Early Detection of Gastric Cancer in Roatan, Honduras: Preliminary Results68274139.7%
2vc3315rAmiloride Derivative Compound 10357 in the Treatment of B-Cell Acute Lymphoblastic Leukemia60184230.0%
0mp2m47jHigh-plex spatial RNA profiling reveals cell type-specific biomarker expression in early-stage melanoma57253243.9%
07k290bwAnalyzing gene expression in androgen resistant prostate cancer54223240.7%
3fj8d062Investigating the role of saposin B in HMA-mediated toxicity toward breast cancer cells52143826.9%

Note: Due to the evolving nature of web traffic, the data presented here should be considered approximate and subject to revision. Learn more.